Innate Pharma SA
Florian DEGACHE has extensive experience in research and development within the biotechnology and biomedical fields. Currently serving as Ingénieur R&D in Bioassay & NAb at Innate Pharma since March 2017, Florian has developed skills in potency assays, proliferation assays, cELISA, and neutralizing antibody assays, alongside expertise in luminescence, fluorescence, and absorbance measurements using advanced plate readers. Previous positions include LifeCycle Technical Assistant at HalioDx, focusing on immunohistochemistry and molecular biology techniques, R&D Technical Assistant at QIAGEN Marseille with a dual role in validation and qualification, and significant technical experience gained as an R&D Technical Assistant at ADNid and a Laboratory Technician at EFS. Florian holds a Diplôme de l’EPHE in SVT with a specialization in Immunology, Oncology, and Cell Biology from École Pratique des Hautes Études and has completed various degrees in biotechnology and biological sciences.
This person is not in any teams
This person is not in any offices
Innate Pharma SA
2 followers
Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of new therapeutic solutions and monoclonal antibodies for the treatment of cancer, as well as for the treatment of infectious diseases and chronic inflammatory pathologies. The Company develops two categories of immunotherapies: immuno-modulators and cytotoxic antibodies. The Company works in collaboration with Bristol-Myers Squibb for Phase I cancer antibody program and with Novo Nordisk A/S for two antibody programs in inflammation treatment. The Company operates through anti-NKG2A antibody, an immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.